目的研究临床治疗中应用依达拉奉和葛根素联合方案对治疗帕金森病的效果。方法 60例帕金森病患者,随机分为试验组和对照组,每组30例。对照组采用常规药物美多芭治疗,试验组采用依达拉奉联合葛根素治疗,对比两组患者的临床治疗效果和不良反应情况。结果试验组患者治疗总有效率为90.0%高于对照组的66.7%,差异具有统计学意义(P<0.05);试验组恶心呕吐、运动障碍、抑郁、厌食等不良反应发生2例(6.7%),对照组发生8例(26.7%),对比差异具有统计学意义(P<0.05)。结论依达拉奉和葛根素联合治疗帕金森病效果显著,具有治疗有效率高、不良反应少的特点,值得推广应用。 Objective To study the effect of combination of edaravone and puerarin on the treatment of Parkinson’s disease in clinical treatment. Methods 60 patients with Parkinson’s disease were randomly divided into experimental group and control group, 30 cases in each group. The control group was treated with metoprolol, a conventional drug. The experimental group was treated with edaravone and puerarin, and the clinical effects and adverse reactions of the two groups were compared. Results The total effective rate of treatment group was 90.0%, which was significantly higher than that of control group (66.7%) (P <0.05). There were 2 cases (6.7%) of nausea and vomiting, dyskinesia, ), 8 cases (26.7%) in the control group, the difference was statistically significant (P <0.05). Conclusion The combination of edaravone and puerarin is effective in treating Parkinson’s disease. It has the characteristics of high treatment efficiency and few adverse reactions, which is worth popularizing and applying.